Form 4: Myomo Inc. Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold shares to cover income taxes resulting from the vesting of a restricted stock unit grant.
Summary
- On July 1, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., sold 12,868 shares of common stock at a price of $3.02 per share.
- The sale was executed to cover income taxes resulting from the vesting of a restricted stock unit grant on June 28, 2024.
- Following the transaction, Kovelman directly owns 132,673 shares of Myomo, Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine transaction to cover tax obligations.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations related to vesting equity grants.
Stakeholder Impact
- The sale could have a minor, temporary impact on the stock price, but is unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| May 12, 2024 | Date of irrevocable election made by the Reporting Party. |
| June 28, 2024 | Date of vesting of a restricted stock unit grant. |
| July 01, 2024 | Date of the transaction (stock sale). |
| July 02, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.